Resistance to paclitaxel is proportional to cellular total antioxidant capacity

Cancer Research

Volumn 65, Issue 18, 2005, Pages 8455-8460

  Ramanathan, Balakrishnan ^a   Jan, Kun Yan ^a   Chen, Chien Hung ^a   Hour, Tzyh Chyuan ^c   Yu, Hong Jen ^b   Pu, Yeong Shiau ^b,d  

^a INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; ARSENIC TRIOXIDE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROGEN; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; SELENIUM; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DNA ADDUCT; DNA DAMAGE; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; BREAST NEOPLASMS; CELL DIVISION; CELL GROWTH PROCESSES; CELL NUCLEUS; DRUG RESISTANCE, NEOPLASM; G2 PHASE; HUMANS; NITRIC OXIDE; PACLITAXEL; REACTIVE OXYGEN SPECIES;

EID: 24944486664     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1162     Document Type: Article

References (33)

1. Bokemeyer C, Hartmann JT, Kuczyk MA, et al. The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors. World J Urol 1996;14:354-9.
2. Rowinsky EK. Paclitaxel pharmacology and other tumor types. Semin Oncol 1997;24:11-2.
3. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A 1980;77:1561-5.
4. Fuchs DA, Johnson RK. Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat Rep 1978;62:1219-22.
5. Lin HL, Liu TY, Chau GY, Lui WY, Chi CW. Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 2000;89:983-94.
6. DiPaola RS. To arrest or not to G(2)-M Cell-cycle arrest. Clin Cancer Res 2002;8:3311-4.
7. Commentary to: Tyagi AK et al. Clin Cancer Res 2002;8:3512-9.
8. Lanzi C, Cassinelli G, Cuccura G, et al. Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells. Prostate 2001;48:254-64.
9. Ioffe ML, White E, Nelson DA, Dvorzhinski D, DiPaola RS. Epothilone induced cytotoxicity is dependent on p53 status in prostate cells. Prostate 2004;61:243-7.
10. Dziadyk JM, Sui M, Zhu X, Fan W. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest. Anticancer Res 2004;24:27-36.
11. Liao PC, Lieu CH. Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cells. Life Sci 2005;76:1623-39.
12. Varbiro G, Veres B, Gallyas F, Jr., Sumegi B. Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med 2001;31:548-58.
13. Wang YF, Chen CY, Chung SF, Chiou YH, Lo HR. Involvement of oxidative stress and caspase activation in paclitaxel-induced apoptosis of primary effusion lymphoma cells. Cancer Chemother Pharmacol 2004;54:322-30.
14. Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR. Taxol induces caspase-10-dependent apoptosis. J Biol Chem 2004;279:51057-67.
15. Choi SC, Oh HM, Park JS, et al. Soluble factor from murine bladder tumor-2 cell elevates nitric oxide production in macrophages and enhances the taxol-mediated macrophage cytotoxicity on tumor cells. Cancer Invest 2003;21:708-9.
16. Pae HO, Yoo JC, Choi BM, Kang CL, Kim JD, Chung HT. Apoptotic cell death induced by taxol is inhibited by nitric oxide in human leukemia HL-60 cells. Immunopharmacol Immunotoxicol 1999;21:667-82.
17. Yu HJ, Tsai TC, Hsieh TS, Chiu TY. Characterization of a newly established human bladder carcinoma cell line, NTUB1. J Formos Med Assoc 1992;91:608-13.
18. Tzeng CC, Liu HS, Li C, et al. Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan. Anticancer Res 1996;16:1797-804.
19. Pu YS, Hsieh TS, Tsai TC, et al. Tamoxifen enhances the chemosensitivity of bladder carcinoma cells. J Urol 1995;154:601-5.
20. Pu YS, Chen J, Huang CY, Guan JY, Lu SH, Hour TC. Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells. J Urol 2001;165:2082-5.
21. Sohn HY, Gloe T, Keller M, Schoenafinger K, Pohl U. Sensitive superoxide detection in vascular cells by the new chemiluminescence dye L-012. J Vasc Res 1999;36:456-64.
22. Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 1997;253:162-8.
23. Eu JP, Liu L, Zeng M, Stamler JS. An apoptotic model for nitrosative stress. Biochemistry 2000;39:1040-7.
24. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 1993;84:407-12.
25. Wang TS, Chung CH, Wang AS, et al. Endonuclease III, formamidopyrimidine- DNA glycosylase, and proteinase K additively enhance arsenic-induced DNA strand breaks in human cells. Chem Res Toxicol 2002;15:1254-8.
26. Gurr JR, Bau DT, Liu F, Lynn S, Jan KY. Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells. Mol Pharmacol 1999;56:102-9.
27. Ide H. DNA substrates containing defined oxidative base lesions and their application to study substrate specificities of base excision repair enzymes. Prog Nucleic Acid Res Mol Biol 2001;68:207-21.
28. Kong Q, Beel JA, Lillehei KO. A threshold concept for cancer therapy. Med Hypotheses 2000;55:29-35.
29. Ling X, Bernacki RJ, Brattain MG, Li F. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest. J Biol Chem 2004;279:15196-203.
30. Kustermans G, El Benna J, Piette J, Legrand-Poels S. Perturbation of actin dynamics induces NF-κB activation in myelomonocytic cells via a NADPH oxidase-dependent pathway. Biochem J 2004;387:531-40.
31. Ollikainen T, Knuuttila A, Suhonen S, et al. In vitro sensitivity of normal human mesothelial and malignant mesothelioma cell lines to four new chemotherapeutic agents. Anticancer Drags 2000;11:93-9.
32. Digue L, Orsiere T, De Meo M, et al. Evaluation of the genotoxic activity of paclitaxel by the in vitro micronucleus test in combination with fluorescent in situ hybridization of a DNA centromeric probe and the alkaline single cell gel electrophoresis technique (comet assay) in human T-lymphocytes. Environ Mol Mutagen 1999;34:269-78.
33. Branham MT, Nadin SB, Vargas-Roig LM, Ciocca DR. DNA damage induced by paclitaxel and DNA repair capability of peripheral blood lymphocytes as evaluated by the alkaline comet assay. Mutat Res 2004;560:11-7.